This website uses cookies

Read our Privacy policy and Terms of use for more information.

⭐ For Premium Partners Only

Intro

❝

🚦 MaxDividends Income System — Buy / Hold / Sell Research List

The role of the Buy / Hold / Sell List inside the system is simple: it removes chaos. Even strongest of investors among us slowly drift into emotional decisions, headline-driven trades, and random buying when there is no clear navigation.

The List We Use for Our Own Dividend Portfolios

It is the same list we use for the MaxDividends team portfolios, for my personal portfolio, and for the portfolios I am building for my kids. These are the dividend businesses we rely on to pay us, grow, and compound income over decades.

The role of the Buy / Hold / Sell List inside the system is simple: it removes chaos. Even the strongest investors among us drift into emotional decisions, headline-driven trades, and random buying when there is no clear navigation.

With this list, we share one common map. At any moment, we know what we buy, what we hold, and what we sell — and why.

That is how capital stays aligned with long-term income, inside the time-tested MaxDividends Income System powered by our dividend intelligence platform.

Every week we analyze thousands of companies across the MaxDividends Universe, evaluating them using Financial Scores, MaxRatio, valuation, dividend discipline, and long-term earnings trends.

The result is a clear Buy / Hold / Sell breakdown of the top dividend names in the market. Just a data-driven snapshot that shows:

  • which companies deserve new capital,

  • which companies we continue compounding with,

  • and which positions our team believes may need to be trimmed or exited.

It's the fastest way to understand where quality is strengthening — and where it's fading.

The structure is simple.

  • The Buy section shows the companies we are actively purchasing now, including with my own capital.

  • The Hold section includes businesses that remain strong but do not qualify for new buying at the moment.

  • The Sell section includes companies that no longer meet the standards of the MaxDividends Income System, with clear reasons provided.

MaxDividends Buy / Hold / Sell Research List

November 2026 Update

Research-backed guidance on quality dividend stocks.

The MaxDividends Research Platform (included in Premium)

MaxDividends BUY-HOLD-SELL-November-26 (next upd 12_17_2026).xlsx

MaxDividends BUY-HOLD-SELL-November-26

182.64 KB • VND.OPENXMLFORMATS-OFFICEDOCUMENT.SPREADSHEETML.SHEET File

This Month’s Changes — Short Summary

This month, we continued raising the quality bar across the Buy List. Our focus remains unchanged: own financially exceptional businesses with durable competitive advantages, growing dividends, and the ability to compound income for decades.

Max’s Comments:

Over the past week, I reviewed the entire list company by company, and together with the team, we updated the statuses. Overall, there were no major changes.

One company is leaving the list, and we’ve added two new investment ideas, both with a Buy rating.

I’ve also refreshed the list of names that will be in my personal focus this month. These are not necessarily “must-buy” stocks — they are simply businesses I’ll be watching closely. I already own many of them in my portfolio, while some are positions I’ve only recently started building or currently have smaller exposure to.

If attractive opportunities come up during the month, I may add to some of these positions. As always, I’ll share any purchases I make in my regular portfolio and buying reports.

All the details are below.

✨ Newly Added

After carefully reviewing the latest edition of Dividend Radar, I decided to add two new companies to our Buy/Hold/Sell list, both with a Buy rating.

These are well-established businesses with strong dividend growth track records. Both have increased their dividends for 14 consecutive years and could become Dividend Eagles next year by reaching their 15th consecutive annual dividend increase.

🍕 Domino’s Pizza (NASDAQ: DPZ)

Domino’s is the world's largest pizza chain, with over 22,100 locations across more than 90 markets. Approximately 99% of its stores are franchised, allowing the company to generate recurring royalty income with relatively low capital requirements.

The company remains interesting thanks to its global expansion, strong brand, and cash-generating franchise model. In 2025, Domino’s opened 776 net new stores and continued gaining market share, supporting its long-term earnings and dividend growth potential.

Key Dividend Metrics:

  • Dividend Safety Score: 97/99

  • Dividend Yield: 2.41%

  • 10-Year Dividend CAGR: 18.83%

  • Annual Dividend: $7.96 per share

  • Payout Ratio: 42.57%

  • Consecutive Dividend Increases: 14 years

  • Valuation: Fairly Valued

💧 Xylem (NYSE: XYL)

Xylem is a global water technology leader operating in approximately 150 countries, with around $9 billion in annual revenue. The company provides essential equipment and technologies for water treatment, distribution, monitoring, and infrastructure management.

Xylem is interesting today because of growing investment in aging water infrastructure, increasing demand for water efficiency, and its expanding presence in industrial markets.

Key Dividend Metrics:

  • Dividend Safety Score: 96/99

  • Dividend Yield: 1.78%

  • 10-Year Dividend CAGR: 11.01%

  • Annual Dividend: $1.72 per share

  • Payout Ratio: 37.61%

  • Consecutive Dividend Increases: 14 years

  • Valuation: Fairly Valued

🟢 Buy — Upgrade

The Buy List now includes 91 Dividend Eagles, down from 93 last month.

The reduction wasn't driven by deteriorating business quality - it reflects our disciplined investment process and today's market environment.

We remain highly selective when adding companies to the Buy List, and valuation continues to matter. Currently, 37 companies are classified as Overvalued, an unusually high number compared with recent months. Many of these remain outstanding businesses, but we're simply waiting for more attractive entry prices before becoming buyers again.

🟡 Hold — Status Update

63 companies currently remain on Hold.

Most status changes were driven by valuation, elevated payout ratios, or Quality Scores falling below our Buy threshold. In many cases, business quality remains intact, but current conditions do not justify additional buying.

One company also moved from Hold to Sell — more on that in the Sell section below.

🔴 Sell — Status Update

Paltac Corp (8283) → Sell

We're downgrading Paltac Corp to Sell.

Reason: Private Acquisition

Paltac Corp is leaving our Buy/Hold/Sell list following a buyout by its parent company, MEDIPAL HOLDINGS CORPORATION (7459.T).

Between May and July 2026, Medipal conducted a tender offer (TOB), increasing its ownership stake to 97.79%. After crossing the 90% threshold, the company initiated a squeeze-out of the remaining minority shareholders at ¥6,650 per share, representing a 43% premium to the market price at the time of the offer.

As a result, Paltac is being removed from our list, with a nice bonus for shareholders in the form of a substantial buyout premium.

—

MaxDividends Income System is a proven system for building income you can live on — powered by our dividend intelligence platform.

We help you get paid — forever. Live off dividends. On your terms.

With respect for your well-being, Max

💌 Questions or thoughts? Reach me anytime at [email protected]

⭐️ Private • For Premium Members Only

📚 Knowledge Base & Premium Guides

Learn the MaxDividends Way

Start Here

Guides & Step-by-Step

Deep Insights

Help & Support

💡 MaxDividends Mission: Helping people build growing passive income, retire early, and live off dividends.

*Disclaimer: This article reflects the author’s personal opinions and is intended for educational and entertainment purposes only. It does not constitute financial advice in any form. Always do your own research and consult a licensed financial advisor. The author may hold positions in some of the stocks mentioned, in line with the views expressed. This is a disclosure, not a recommendation to buy or sell any securities.
As a reader of MaxDividends, you agree to our disclaimer. You can read the full disclaimer here.